- Home
- DYN vs ITGR Comparison
DYN vs ITGR Comparison
Compare DYN & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DYN | ITGR |
|---|---|---|
| Founded | 1984 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.3B |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | DYN | ITGR |
|---|---|---|
| Price | $25.94 | $124.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 7 |
| Target Price | $37.00 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 2.6M | 1.0M |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | N/A | $1.69 |
| Revenue Next Year | N/A | $6.53 |
| P/E Ratio | ★ N/A | $259.27 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $9.89 | $62.00 |
| 52 Week High | $26.62 | $125.54 |
Technical Indicators
Market Signals| Indicator | DYN | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 63.41 | 84.97 |
| Support Level | $16.00 | $82.58 |
| Resistance Level | $26.62 | N/A |
| Average True Range (ATR) | 1.47 | 3.88 |
| MACD | -0.02 | 2.97 |
| Stochastic Oscillator | 87.27 | 97.05 |
Price Performance
Historical ComparisonAbout DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.